BIOMAT Database Logo BIOMAT Database Logo

[Characteristics of the formation of the HBsAg carrier state among pregnant women and newborn infants and their role in the spread of hepatitis B]. 1988

M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov

The authors analyze the incidence rate of HBsAg carriership among 8, 120 pregnant women and 261 newborn infants at different periods after birth. The levels of HBsAg carriership among pregnant women and the members of their families, as well as among the personnel of maternity clinics and blood donors, have been established. The rate and time of the detection of HBsAg in infants born to mothers found to be HBsAg carriers have been determined. Measures for the prophylaxis of hepatitis B are discussed with due regard to the specific epidemiological features of the spread of HBsAg carriership, established in this study, and to the presence of antibodies to HBsAg among the above-mentioned groups of the population.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia

Related Publications

M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
[Incidence of the HBsAg carrier state among pregnant women and its effect on newborn infants. I. The incidence of the HBsAg carrier state among pregnant women in different provinces of Bulgaria].
January 1987, Akusherstvo i ginekologiia,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
[The prevalence of the HBsAg carrier state among pregnant women and its effect on newborn infants. IV. Our experience in using hepatitis B vaccine and hepatitis B immunoglobulin to immunize infants born to mothers who carry HBsAg].
January 1989, Akusherstvo i ginekologiia,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
[The incidence of the HBsAg carrier state among pregnant women and its effect on newborn infants. III. Viral hepatitis morbidity among the infants born to mothers who are HBsAg carriers].
January 1988, Akusherstvo i ginekologiia,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
[The vaccinal prevention of the HBsAg carrier state among newborn infants].
January 1991, Voprosy virusologii,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
[Carrier state of hepatitis B virus in pregnant women: problem of the protection of newborn infants from infection].
December 1984, Ginekologia polska,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
[The prevalence of the HBsAg carrier state among pregnant women and its effect on newborn infants. V. A follow-up of the processes of HBsAg clearance in pregnant women discovered as antigen carriers].
January 1993, Akusherstvo i ginekologiia,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
Hepatitis B in Pregnant Women and their Infants.
August 2019, Clinics in liver disease,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
June 1986, Asian Pacific journal of allergy and immunology,
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin.
September 1979, Lancet (London, England),
M A Gorbunov, and A A Sumarokov, and V N Ikoev, and I Iu Iarosheskaia, and M K Sharipov
[Incidence of the HBsAg carrier state among pregnant women and its effect on the newborn infant. II. The presence of hepatitis B and delta markers in the umbilical cord serum of infants born to mothers who are HBsAg carriers].
January 1987, Akusherstvo i ginekologiia,
Copied contents to your clipboard!